bovis/BCG narK2X promoter inactive. To confirm that no other trans-acting factor (e.g. repressor) contributed to the loss of promoter activity in M. bovis/BCG, the pnarK2 plasmid (harbouring the M. tb WT narK2 promoter) was introduced into M. bovis and BCG strains and the GFP reporter assay was performed under hypoxic conditions. The M. tb WT narK2X promoter was well induced and to the same level in M. bovis and BCG as in M. tb (Table 3), which suggests that the −6TC mutation, and not a trans-acting negative regulator, is responsible for the absence

of narK2X promoter activity in M. bovis and BCG. To further validate that the M. tb narK2X promoter behaves similarly in M. bovis/BCG and M. tb, two additional truncated narK2X promoter GSK1120212 cost selleck GFP reporter constructs pnarK2Δdown and pnarK2Δup (described in Chauhan & Tyagi,

2008a) were also assessed for GFP fluorescence in M. bovis and BCG under hypoxic conditions. In pnarK2Δdown, the so-called ‘downstream inhibitory region’ is removed (+14 to +57 with respect to M. tb narK2X TSP), whereas in pnarK2Δup, the so-called ‘upstream activating region’ (described by Hutter & Dick, 2000) is deleted (−122 to −220 relative to M. tb narK2X TSP). A similar level of hypoxic induction was observed for both promoter constructs in all three strains (Table 3), demonstrating that the M. tb narK2X promoter has similar activity in M. tb, M. bovis and BCG. These results suggest that all the trans-acting (including DevR) and cis elements that control the narK2X promoter are functionally conserved in M. tb, M. bovis and BCG, except for the −6T/C SNP. A putative −10 element was recognized upstream of the experimentally detected TSP of narK2 that was reported previously (Chauhan & Tyagi, 2008a). In the present study, it was functionally characterized by individually mutating additional nucleotides at −4, −5, −7 and −8 positions with respect to the TSP (Fig. 1).

Both −4AC Tacrolimus (FK506) and −5TC mutations significantly or completely reduced the promoter activity and demonstrated the importance of these nucleotides in promoter function. Taken together, the results of mutation analysis indicate that ‘ATT’ nucleotides present at −4, −5 and −6 positions are essential for promoter activity and likely to be recognized by the transcriptional machinery. Note that the −5TC mutation was reported to be present in BCG by Hutter and Dick (2000), and the introduction of this mutation significantly reduced inducible promoter activity by ∼7-fold, but did not abolish it (Fig. 1). The −7GC or −8GT mutations, which also altered the overlapping putative SigC −10 sequence, did not adversely affect narK2X promoter activity. Although the −10 element of the narK2X promoter showed only a modest resemblance (2/6) to the SigA consensus sequence (Unniraman et al.